The biosimilar manufacturer then tells the patent holder which patents it believes the biosimilar would not infringe or are invalid. Id. § 262(l)(3)(B). Next, …
The biosimilar manufacturer then tells the patent holder which patents it believes the biosimilar would not infringe or are invalid. Id. § 262(l)(3)(B). Next, …